The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BLACK STONE MINERALS | Common | 09225M101 | 10,857,819 | 643,617 | SH | SOLE | 643,617 | 0 | 0 | |||
| UNITY BIOTECHNOLOGY INC | Common | 91381U101 | 430,723 | 157,198 | SH | SOLE | 157,198 | 0 | 0 | |||
| EVELO BIOSCIENCES INC | Common | 299734103 | 771,580 | 479,242 | SH | SOLE | 479,242 | 0 | 0 | |||
| Clearpoint Neuro Inc | Common | 18507C103 | 322,826 | 38,114 | SH | SOLE | 38,114 | 0 | 0 | |||
| BIOSIG TECH INC | Common | 09073N201 | 42,374 | 100,891 | SH | SOLE | 100,891 | 0 | 0 | |||
| Zentalis Pharmaceuticals Inc | Common | 98943L107 | 5,984,460 | 297,143 | SH | SOLE | 297,143 | 0 | 0 | |||
| Sorento Therapeutics | Common | 83587F202 | 267,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| Teladoc Health Inc Com | Common | 87918A105 | 15,585 | 659 | SH | SOLE | 659 | 0 | 0 | |||
| Neuroon Medical Technologies | Common | 64130M209 | 218,105 | 181,754 | SH | SOLE | 181,754 | 0 | 0 | |||
| Exact Sciences | Common | 30063P105 | 180,959 | 3,655 | SH | SOLE | 3,655 | 0 | 0 | |||
| Vyant Bio Inc | Common | 92942V208 | 19,419 | 27,742 | SH | SOLE | 27,742 | 0 | 0 | |||
| Miromatrix Med Inc | Common | 60471P108 | 572,950 | 191,622 | SH | SOLE | 191,622 | 0 | 0 | |||
| MSCI ACWI ETF | Common | 464288257 | 169,142,498 | 1,992,725 | SH | SOLE | 1,992,725 | 0 | 0 | |||